Corcept Therapeutics (CORT) Change in Inventory (2012 - 2026)
Corcept Therapeutics (CORT) reported Change in Inventory of $3.3 million for Q1 2026, up 640.83% on a YoY basis from $441668.9 in Q1 2025, and up 777.43% sequentially from -$483000.0 in Q4 2025.
Corcept Therapeutics (CORT) Change in Inventory (2012 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 15 years of Change in Inventory data on file, last reported at $3.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 640.83% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $11.4 million (up 15458.9% YoY), and the FY2025 full-year result was $7.5 million, up 2552.79% from the prior year.
- Change in Inventory improved to $3.3 million in Q1 2026, from -$483000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $4.6 million in Q2 2025 to a low of -$1.1 million in Q3 2024.
- A 5-year average of $469647.1 and a median of -$329000.0 in 2023 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory tumbled 719.23% in 2025 and surged 640.83% in 2026, its largest moves.
- Tracing CORT's Change in Inventory over 5 years: stood at -$125000.0 in 2022, then plunged by 163.2% to -$329000.0 in 2023, then soared by 123.71% to $78000.0 in 2024, then plunged by 719.23% to -$483000.0 in 2025, then soared by 777.43% to $3.3 million in 2026.
- Business Quant data shows CORT's Change in Inventory at $3.3 million in Q1 2026, -$483000.0 in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corcept Therapeutics | 10.09 Bn | 9.76 Bn | 162.02 Mn | 3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.27 Mn |
| Mar 31, 2026 | 3.27 Mn |
| Dec 31, 2025 | -483,000.00 |
| Dec 31, 2025 | -483,000.00 |
| Sep 30, 2025 | 3.94 Mn |
| Sep 30, 2025 | 3.94 Mn |
| Jun 30, 2025 | 4.63 Mn |
| Jun 30, 2025 | 4.63 Mn |
| Mar 31, 2025 | -605,000.00 |
| Mar 31, 2025 | -605,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Sep 30, 2024 | -1.08 Mn |
| Sep 30, 2024 | -1.08 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | -983,000.00 |
| Mar 31, 2024 | -983,000.00 |
| Dec 31, 2023 | -329,000.00 |
| Dec 31, 2023 | -329,000.00 |